Barry Bresnihan
Department of Rheumatology
St. Vincent's University Hospital
and The Conway Institute of Biomolecular and Biomedical Research
University College Dublin
Ireland
Name/email consistency: high
- Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. Bresnihan, B., Gerlag, D.M., Rooney, T., Smeets, T.J., Wijbrandts, C.A., Boyle, D., Fitzgerald, O., Kirkham, B.W., McInnes, I.B., Smith, M., Ulfgren, A.K., Veale, D.J., Tak, P.P. J. Rheumatol. (2007)
- Synovial biomarkers in the spondylarthropathies. Bresnihan, B. Curr. Opin. Rheumatol (2006)
- Sonography and subclinical synovitis. Bresnihan, B., Kane, D. Ann. Rheum. Dis. (2004)
- Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial. Bresnihan, B., Newmark, R., Robbins, S., Genant, H.K. J. Rheumatol. (2004)
- Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Bresnihan, B., Cobby, M. Rheumatology. (Oxford) (2003)
- Are synovial biopsies of diagnostic value?. Bresnihan, B. Arthritis Res. Ther. (2003)
- Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Bresnihan, B., Roux-Lombard, P., Murphy, E., Kane, D., FitzGerald, O., Dayer, J.M. Ann. Rheum. Dis. (2002)
- Preventing joint damage as the best measure of biologic drug therapy. Bresnihan, B. J. Rheumatol. Suppl (2002)